Ads
related to: sanofi stockdirexion.com has been visited by 100K+ users in the past month
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Bull & Bear 3X ETFs
Search results
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 4 days agoIn contrast, Moderna has more than 40 candidates in the pipeline, and as mentioned above, expects to launch several products within the next few years....
Major European Markets Close Weak After Cautious Session
RTT News· 2 hours agoEuropean stocks closed lower on Tuesday with investors largely staying cautious, looking ahead to the release of minutes from the Federal Reserve's most recent policy meeting, and a report on U.
Up 3x In A Week, Will Novavax Stock Continue To See Higher Levels?
Forbes· 5 days agoNVAX stock was trading at around $51 in early June 2022, just before the Fed started increasing...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks· 14 hours agoFree Report) announced its long-term plan to generate $80 billion in total revenues by 2030, which is significantly higher than $43.8 million generated in 2023. By 2030, AstraZeneca plans to ...
France stocks mixed at close of trade; CAC 40 up 0.17% By Investing.com
Investing.com· 6 days agoFrance stocks mixed at close of trade; CAC 40 up 0.17%
3 Stocks Under $2 That Can Trade in Double Digits by 2025
InvestorPlace via Yahoo Finance· 6 days agoInvestors tend to be interested in low-priced stocks. A probable reason is having a diversified...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 4 days agoModerna fared well, dominating the vaccine market along with big pharma rival Pfizer, and bringing...
Earnings call: DarioHealth projects growth and profitability by 2025 By Investing.com
Investing.com· 6 days agoIn a recent earnings call, DarioHealth Corp (NASDAQ:DRIO) CEO Erez Raphael outlined the company's...
Analyst Upgrades: 3 Stocks Getting the Nod From Pros Last Week
InvestorPlace· 5 days agoThe S&P 500 is on the longest streak since February, partly buoyed by stocks with analyst upgrades....
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 5 days agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
